RLAY - Relay Therapeutics, Inc.

QQQ $ 603.18 $ -5.15 (-0.85 %)

DIA $ 467.70 $ -0.51 (-0.11 %)

SPY $ 664.75 $ -3.30 (-0.49 %)

TLT $ 89.61 $ 0.25 (0.28 %)

GLD $ 366.77 $ -1.17 (-0.32 %)

Previous Close

$ 6.53

Open

$ 6.18

Bid

$ 6.13 x 7

Ask

$ 6.14 x 300

Day's Range

$ 6.05 - $ 6.68

52 Week Range

$ 1.78 - $ 7.64

Volume

1,968,485

Average Volume

Market Cap

1.13B

Beta (5Y Monthly)

$ 1.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-05-2025	03-31-2025	10-Q
4	02-26-2025	12-31-2024	10-K
5	11-06-2024	09-30-2024	10-Q
6	08-06-2024	06-30-2024	10-Q
7	05-02-2024	03-31-2024	10-Q
8	02-22-2024	12-31-2023	10-K
9	11-02-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-04-2023	03-31-2023	10-Q
12	02-23-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-12-2021	06-30-2021	10-Q
19	05-13-2021	03-31-2021	10-Q
20	03-25-2021	12-31-2020	10-K
21	11-12-2020	09-30-2020	10-Q
22	08-27-2020	06-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Relay Therapeutics Q3 EPS $(0.43) Misses $...
11/06/2025 21:26:29

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of ...

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Guggenheim Assumes Relay Therapeutics at B...
09/04/2025 14:10:24

Guggenheim analyst Brad Canino assumes Relay Therapeutics (NASDAQ:RLAY) with a Buy rating and announces Price Target of $15.

medtronic-to-rally-around-25-here-are-10-top-analyst-forecasts-for-tuesday

Medtronic To Rally Around 25%? Here Are 10...
08/26/2025 13:40:26

HC Wainwright & Co. Maintains Buy on Relay...
08/26/2025 11:12:30

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price targ...

Raymond James Maintains Strong Buy on Rela...
08/08/2025 16:14:14

Raymond James analyst Dane Leone maintains Relay Therapeutics (NASDAQ:RLAY) with a Strong Buy and lowers the price target fr...

Relay Therapeutics Q2 EPS $(0.41) Beats $(...
08/07/2025 20:10:53

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Preview: Relay Therapeutics's Earnings
08/06/2025 18:09:09

Relay Therapeutics Says Updated Interim Cl...
06/02/2025 11:03:24

Updated interim data remain consistent, showing 10.3-month median PFS overall and 11.0-month median PFS in 2L patients with PI3...

Guggenheim Maintains Buy on Relay Therapeu...
05/07/2025 15:16:04

Guggenheim analyst Michael Schmidt maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price target from $3...

Relay Therapeutics Q1 EPS $(0.46) Beats $(...
05/05/2025 20:16:28

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(...

this-twin-disc-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday

This Twin Disc Analyst Begins Coverage On ...
04/17/2025 12:50:40

Wells Fargo Initiates Coverage On Relay Th...
04/17/2025 12:04:56

Wells Fargo initiates coverage on Relay Therapeutics (NASDAQ:RLAY) with a Equal-Weight rating and announces Price Target of $4.

HC Wainwright & Co. Reiterates Buy on Rela...
03/07/2025 12:38:12

HC Wainwright & Co. analyst Robert Burns reiterates Relay Therapeutics (NASDAQ:RLAY) with a Buy and maintains $16 price ...

Goldman Sachs Maintains Buy on Relay Thera...
02/27/2025 17:03:58

Goldman Sachs analyst Salveen Richter maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price target from...

Stifel Maintains Buy on Relay Therapeutics...
02/27/2025 15:37:29

Stifel analyst Bradley Canino maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price target from $27 to ...

Relay Therapeutics Q4 GAAP EPS $(0.45) Bea...
02/26/2025 21:27:44

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For February 26, 2025
02/26/2025 08:32:32

HC Wainwright & Co. Reiterates Buy on Rela...
01/14/2025 12:58:19

HC Wainwright & Co. analyst Robert Burns reiterates Relay Therapeutics (NASDAQ:RLAY) with a Buy and maintains $16 price ...